Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 307 entries
Sorted by: Best Match Show Resources per page
A novel PSENEN mutation in a patient with complaints of memory loss and a family history of dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association

Albani D, Batelli S, Pesaresi M, Prato F, Polito L, Forloni G, Pantieri R.
PMID: 19595943
Alzheimers Dement. 2007 Jul;3(3):235-8. doi: 10.1016/j.jalz.2007.04.375.

Presenilin enhancer-2 (PSENEN) is a fundamental component of the gamma-secretase protein complex involved in beta-amyloid precursor protein (beta APP) processing, a key event in Alzheimer's disease (AD) etiopathogenesis. In a mild cognitive impairment (MCI)-diagnosed woman, belonging to a family...

Cite
Albani D, Batelli S, Pesaresi M, et al. A novel PSENEN mutation in a patient with complaints of memory loss and a family history of dementia. Alzheimers Dement. 2007;3(3):235-8doi: 10.1016/j.jalz.2007.04.375.
Albani, D., Batelli, S., Pesaresi, M., Prato, F., Polito, L., Forloni, G., & Pantieri, R. (2007). A novel PSENEN mutation in a patient with complaints of memory loss and a family history of dementia. Alzheimer's & dementia : the journal of the Alzheimer's Association, 3(3), 235-8. https://doi.org/10.1016/j.jalz.2007.04.375
Albani, Diego, et al. "A novel PSENEN mutation in a patient with complaints of memory loss and a family history of dementia." Alzheimer's & dementia : the journal of the Alzheimer's Association vol. 3,3 (2007): 235-8. doi: https://doi.org/10.1016/j.jalz.2007.04.375
Albani D, Batelli S, Pesaresi M, Prato F, Polito L, Forloni G, Pantieri R. A novel PSENEN mutation in a patient with complaints of memory loss and a family history of dementia. Alzheimers Dement. 2007 Jul;3(3):235-8. doi: 10.1016/j.jalz.2007.04.375. PMID: 19595943.
Copy Download .nbib Format: NLM
The rs2030324 SNP of brain-derived neurotrophic factor (BDNF) is associated with visual cognitive processing in multiple sclerosis.

Pathophysiology : the official journal of the International Society for Pathophysiology

Weinstock-Guttman B, Benedict RH, Tamaño-Blanco M, Ramasamy DP, Stosic M, Polito J, Zivadinov R, Ramanathan M.
PMID: 20547043
Pathophysiology. 2011 Feb;18(1):43-52. doi: 10.1016/j.pathophys.2010.04.005. Epub 2010 May 23.

PURPOSE: To investigate the associations between the rs2030324 SNP of brain-derived neurotrophic factor (BDNF) and neuropsychological (NP) test measures in multiple sclerosis (MS) patients.BACKGROUND: BDNF regulates the survival of neuronal and non-neuronal cells and plays a critical role in...

Cite
Weinstock-Guttman B, Benedict RH, Tamaño-Blanco M, et al. The rs2030324 SNP of brain-derived neurotrophic factor (BDNF) is associated with visual cognitive processing in multiple sclerosis. Pathophysiology. 2010;18(1):43-52doi: 10.1016/j.pathophys.2010.04.005.
Weinstock-Guttman, B., Benedict, R. H., Tamaño-Blanco, M., Ramasamy, D. P., Stosic, M., Polito, J., Zivadinov, R., & Ramanathan, M. (2011). The rs2030324 SNP of brain-derived neurotrophic factor (BDNF) is associated with visual cognitive processing in multiple sclerosis. Pathophysiology : the official journal of the International Society for Pathophysiology, 18(1), 43-52. https://doi.org/10.1016/j.pathophys.2010.04.005
Weinstock-Guttman, Bianca, et al. "The rs2030324 SNP of brain-derived neurotrophic factor (BDNF) is associated with visual cognitive processing in multiple sclerosis." Pathophysiology : the official journal of the International Society for Pathophysiology vol. 18,1 (2011): 43-52. doi: https://doi.org/10.1016/j.pathophys.2010.04.005
Weinstock-Guttman B, Benedict RH, Tamaño-Blanco M, Ramasamy DP, Stosic M, Polito J, Zivadinov R, Ramanathan M. The rs2030324 SNP of brain-derived neurotrophic factor (BDNF) is associated with visual cognitive processing in multiple sclerosis. Pathophysiology. 2011 Feb;18(1):43-52. doi: 10.1016/j.pathophys.2010.04.005. Epub 2010 May 23. PMID: 20547043.
Copy Download .nbib Format: NLM
A novel study and meta-analysis of the genetic variation of the serotonin transporter promoter in the italian population do not support a large effect on Alzheimer's disease risk.

International journal of Alzheimer's disease

Polito L, Prato F, Rodilossi S, Ateri E, Galimberti D, Scarpini E, Clerici F, Mariani C, Forloni G, Albani D.
PMID: 21660253
Int J Alzheimers Dis. 2011;2011:312341. doi: 10.4061/2011/312341. Epub 2011 Jun 02.

Alzheimer's disease (AD) is a neurodegenerative disorder whose clinical onset is mainly characterized by memory loss. During AD progression, behavioral and psychological symptoms of dementia (BPSD) frequently occur. In this paper we evaluated the association between AD and the...

Cite
Polito L, Prato F, Rodilossi S, et al. A novel study and meta-analysis of the genetic variation of the serotonin transporter promoter in the italian population do not support a large effect on Alzheimer's disease risk. Int J Alzheimers Dis. 2011;2011:312341doi: 10.4061/2011/312341.
Polito, L., Prato, F., Rodilossi, S., Ateri, E., Galimberti, D., Scarpini, E., Clerici, F., Mariani, C., Forloni, G., & Albani, D. (2011). A novel study and meta-analysis of the genetic variation of the serotonin transporter promoter in the italian population do not support a large effect on Alzheimer's disease risk. International journal of Alzheimer's disease, 2011312341. https://doi.org/10.4061/2011/312341
Polito, Letizia, et al. "A novel study and meta-analysis of the genetic variation of the serotonin transporter promoter in the italian population do not support a large effect on Alzheimer's disease risk." International journal of Alzheimer's disease vol. 2011 (2011): 312341. doi: https://doi.org/10.4061/2011/312341
Polito L, Prato F, Rodilossi S, Ateri E, Galimberti D, Scarpini E, Clerici F, Mariani C, Forloni G, Albani D. A novel study and meta-analysis of the genetic variation of the serotonin transporter promoter in the italian population do not support a large effect on Alzheimer's disease risk. Int J Alzheimers Dis. 2011;2011:312341. doi: 10.4061/2011/312341. Epub 2011 Jun 02. PMID: 21660253; PMCID: PMC3109656.
Copy Download .nbib Format: NLM
Five-year treatment of chronic venous insufficiency with O-(β-hydroxyethyl)-rutosides: safety aspects.

The International journal of angiology : official publication of the International College of Angiology, Inc

Stuard S, Cesarone MR, Belcaro G, Dugall M, Ledda A, Cacchio M, Ricci A, Ippolito E, Di Renzo A, Grossi MG.
PMID: 22477419
Int J Angiol. 2008;17(3):143-8. doi: 10.1055/s-0031-1278299.

Chronic venous insufficiency (CVI), and related signs and symptoms of venous and diabetic microangiopathy, can be effectively treated with O-(β-hydroxyethyl)-rutosides (HR). The aim of the present independent registry study was to evaluate HR in a long-term (five-year) period of...

Cite
Stuard S, Cesarone MR, Belcaro G, et al. Five-year treatment of chronic venous insufficiency with O-(β-hydroxyethyl)-rutosides: safety aspects. Int J Angiol. 2008;17(3):143-8doi: 10.1055/s-0031-1278299.
Stuard, S., Cesarone, M. R., Belcaro, G., Dugall, M., Ledda, A., Cacchio, M., Ricci, A., Ippolito, E., Di Renzo, A., & Grossi, M. G. (2008). Five-year treatment of chronic venous insufficiency with O-(β-hydroxyethyl)-rutosides: safety aspects. The International journal of angiology : official publication of the International College of Angiology, Inc, 17(3), 143-8. https://doi.org/10.1055/s-0031-1278299
Stuard, S, et al. "Five-year treatment of chronic venous insufficiency with O-(β-hydroxyethyl)-rutosides: safety aspects." The International journal of angiology : official publication of the International College of Angiology, Inc vol. 17,3 (2008): 143-8. doi: https://doi.org/10.1055/s-0031-1278299
Stuard S, Cesarone MR, Belcaro G, Dugall M, Ledda A, Cacchio M, Ricci A, Ippolito E, Di Renzo A, Grossi MG. Five-year treatment of chronic venous insufficiency with O-(β-hydroxyethyl)-rutosides: safety aspects. Int J Angiol. 2008;17(3):143-8. doi: 10.1055/s-0031-1278299. PMID: 22477419; PMCID: PMC2727765.
Copy Download .nbib Format: NLM
Five-year treatment of chronic venous insufficiency with O-(β-hydroxyethyl)-rutosides: safety aspects.

The International journal of angiology : official publication of the International College of Angiology, Inc

Stuard S, Cesarone MR, Belcaro G, Dugall M, Ledda A, Cacchio M, Ricci A, Ippolito E, Di Renzo A, Grossi MG.
PMID: 22477419
Int J Angiol. 2008;17(3):143-8. doi: 10.1055/s-0031-1278299.

Chronic venous insufficiency (CVI), and related signs and symptoms of venous and diabetic microangiopathy, can be effectively treated with O-(β-hydroxyethyl)-rutosides (HR). The aim of the present independent registry study was to evaluate HR in a long-term (five-year) period of...

Cite
Stuard S, Cesarone MR, Belcaro G, et al. Five-year treatment of chronic venous insufficiency with O-(β-hydroxyethyl)-rutosides: safety aspects. Int J Angiol. 2008;17(3):143-8doi: 10.1055/s-0031-1278299.
Stuard, S., Cesarone, M. R., Belcaro, G., Dugall, M., Ledda, A., Cacchio, M., Ricci, A., Ippolito, E., Di Renzo, A., & Grossi, M. G. (2008). Five-year treatment of chronic venous insufficiency with O-(β-hydroxyethyl)-rutosides: safety aspects. The International journal of angiology : official publication of the International College of Angiology, Inc, 17(3), 143-8. https://doi.org/10.1055/s-0031-1278299
Stuard, S, et al. "Five-year treatment of chronic venous insufficiency with O-(β-hydroxyethyl)-rutosides: safety aspects." The International journal of angiology : official publication of the International College of Angiology, Inc vol. 17,3 (2008): 143-8. doi: https://doi.org/10.1055/s-0031-1278299
Stuard S, Cesarone MR, Belcaro G, Dugall M, Ledda A, Cacchio M, Ricci A, Ippolito E, Di Renzo A, Grossi MG. Five-year treatment of chronic venous insufficiency with O-(β-hydroxyethyl)-rutosides: safety aspects. Int J Angiol. 2008;17(3):143-8. doi: 10.1055/s-0031-1278299. PMID: 22477419; PMCID: PMC2727765.
Copy Download .nbib Format: NLM
Dyspnea in hemodialysis and early echocardiographic examination at the bedside: Two case reports.

Journal of ultrasound

Di Lullo L, Floccari F, Granata A, Fiorini F, Polito P.
PMID: 23397469
J Ultrasound. 2011 Sep;14(3):110-2. doi: 10.1016/j.jus.2011.06.003. Epub 2011 Jun 28.

No abstract available.

Cite
Di Lullo L, Floccari F, Granata A, et al. Dyspnea in hemodialysis and early echocardiographic examination at the bedside: Two case reports. J Ultrasound. 2011;14(3):110-2doi: 10.1016/j.jus.2011.06.003.
Di Lullo, L., Floccari, F., Granata, A., Fiorini, F., & Polito, P. (2011). Dyspnea in hemodialysis and early echocardiographic examination at the bedside: Two case reports. Journal of ultrasound, 14(3), 110-2. https://doi.org/10.1016/j.jus.2011.06.003
Di Lullo, L, et al. "Dyspnea in hemodialysis and early echocardiographic examination at the bedside: Two case reports." Journal of ultrasound vol. 14,3 (2011): 110-2. doi: https://doi.org/10.1016/j.jus.2011.06.003
Di Lullo L, Floccari F, Granata A, Fiorini F, Polito P. Dyspnea in hemodialysis and early echocardiographic examination at the bedside: Two case reports. J Ultrasound. 2011 Sep;14(3):110-2. doi: 10.1016/j.jus.2011.06.003. Epub 2011 Jun 28. PMID: 23397469; PMCID: PMC3558241.
Copy Download .nbib Format: NLM
An MRI volumetric study for leg muscles in congenital clubfoot.

Journal of children's orthopaedics

Ippolito E, Dragoni M, Antonicoli M, Farsetti P, Simonetti G, Masala S.
PMID: 24082959
J Child Orthop. 2012 Oct;6(5):433-8. doi: 10.1007/s11832-012-0444-9. Epub 2012 Oct 05.

PURPOSE: To investigate both volume and length of the three muscle compartments of the normal and the affected leg in unilateral congenital clubfoot.METHODS: Volumetric magnetic resonance imaging (VMRI) of the anterior, lateral and postero-medial muscular compartments of both the...

Cite
Ippolito E, Dragoni M, Antonicoli M, et al. An MRI volumetric study for leg muscles in congenital clubfoot. J Child Orthop. 2012;6(5):433-8doi: 10.1007/s11832-012-0444-9.
Ippolito, E., Dragoni, M., Antonicoli, M., Farsetti, P., Simonetti, G., & Masala, S. (2012). An MRI volumetric study for leg muscles in congenital clubfoot. Journal of children's orthopaedics, 6(5), 433-8. https://doi.org/10.1007/s11832-012-0444-9
Ippolito, Ernesto, et al. "An MRI volumetric study for leg muscles in congenital clubfoot." Journal of children's orthopaedics vol. 6,5 (2012): 433-8. doi: https://doi.org/10.1007/s11832-012-0444-9
Ippolito E, Dragoni M, Antonicoli M, Farsetti P, Simonetti G, Masala S. An MRI volumetric study for leg muscles in congenital clubfoot. J Child Orthop. 2012 Oct;6(5):433-8. doi: 10.1007/s11832-012-0444-9. Epub 2012 Oct 05. PMID: 24082959; PMCID: PMC3468731.
Copy Download .nbib Format: NLM
A novel way to get out of the cell.

Cytotechnology

Rubartelli A, Bajetto A, Bonifaci N, Di Blas E, Solito E, Sitia R.
PMID: 22358704
Cytotechnology. 1993 Jan;11:S37-40. doi: 10.1007/BF00746049.

No abstract available.

Cite
Rubartelli A, Bajetto A, Bonifaci N, et al. A novel way to get out of the cell. Cytotechnology. 1993;11:S37-40doi: 10.1007/BF00746049.
Rubartelli, A., Bajetto, A., Bonifaci, N., Di Blas, E., Solito, E., & Sitia, R. (1993). A novel way to get out of the cell. Cytotechnology, 11S37-40. https://doi.org/10.1007/BF00746049
Rubartelli, A, et al. "A novel way to get out of the cell." Cytotechnology vol. 11 (1993): S37-40. doi: https://doi.org/10.1007/BF00746049
Rubartelli A, Bajetto A, Bonifaci N, Di Blas E, Solito E, Sitia R. A novel way to get out of the cell. Cytotechnology. 1993 Jan;11:S37-40. doi: 10.1007/BF00746049. PMID: 22358704.
Copy Download .nbib Format: NLM
Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives.

Biomedicines

Mercatelli D, Bortolotti M, Bazzocchi A, Bolognesi A, Polito L, Eigenmann PA.
PMID: 29439419
Biomedicines. 2018 Feb 10;6(1). doi: 10.3390/biomedicines6010019.

Osteosarcoma (OS) is an aggressive osteoid-producing tumor of mesenchymal origin, which represents the most common primary bone malignancy. It is characterized by a complex and frequently uncertain etiology. The current standard care for high-grade OS treatment is neoadjuvant chemotherapy,...

Cite
Mercatelli D, Bortolotti M, Bazzocchi A, et al. Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives. Biomedicines. 2018;6(1)doi: 10.3390/biomedicines6010019.
Mercatelli, D., Bortolotti, M., Bazzocchi, A., Bolognesi, A., Polito, L., & Eigenmann, P. A. (2018). Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives. Biomedicines, 6(1), . https://doi.org/10.3390/biomedicines6010019
Mercatelli, Daniele, et al. "Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives." Biomedicines vol. 6,1 (2018). doi: https://doi.org/10.3390/biomedicines6010019
Mercatelli D, Bortolotti M, Bazzocchi A, Bolognesi A, Polito L, Eigenmann PA. Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives. Biomedicines. 2018 Feb 10;6(1). doi: 10.3390/biomedicines6010019. PMID: 29439419; PMCID: PMC5874676.
Copy Download .nbib Format: NLM
Nanolipid-Trehalose Conjugates and Nano-Assemblies as Putative Autophagy Inducers.

Pharmaceutics

Colombo E, Biocotino M, Frapporti G, Randazzo P, Christodoulou MS, Piccoli G, Polito L, Seneci P, Passarella D.
PMID: 31434235
Pharmaceutics. 2019 Aug 20;11(8). doi: 10.3390/pharmaceutics11080422.

The disaccharide trehalose is an autophagy inducer, but its pharmacological application is severely limited by its poor pharmacokinetics properties. Thus, trehalose was coupled via suitable spacers with squalene (in 1:2 and 1:1 stoichiometry) and with betulinic acid (1:2 stoichiometry),...

Cite
Colombo E, Biocotino M, Frapporti G, et al. Nanolipid-Trehalose Conjugates and Nano-Assemblies as Putative Autophagy Inducers. Pharmaceutics. 2019;11(8)doi: 10.3390/pharmaceutics11080422.
Colombo, E., Biocotino, M., Frapporti, G., Randazzo, P., Christodoulou, M. S., Piccoli, G., Polito, L., Seneci, P., & Passarella, D. (2019). Nanolipid-Trehalose Conjugates and Nano-Assemblies as Putative Autophagy Inducers. Pharmaceutics, 11(8), . https://doi.org/10.3390/pharmaceutics11080422
Colombo, Eleonora, et al. "Nanolipid-Trehalose Conjugates and Nano-Assemblies as Putative Autophagy Inducers." Pharmaceutics vol. 11,8 (2019). doi: https://doi.org/10.3390/pharmaceutics11080422
Colombo E, Biocotino M, Frapporti G, Randazzo P, Christodoulou MS, Piccoli G, Polito L, Seneci P, Passarella D. Nanolipid-Trehalose Conjugates and Nano-Assemblies as Putative Autophagy Inducers. Pharmaceutics. 2019 Aug 20;11(8). doi: 10.3390/pharmaceutics11080422. PMID: 31434235; PMCID: PMC6723367.
Copy Download .nbib Format: NLM
Physiological responses, fatigue and perception of female soccer players in small-sided games with different pitch size and sport surfaces.

Biology of sport

López-Fernández J, Sánchez-Sánchez J, Rodríguez-Cañamero S, Ubago-Guisado E, Colino E, Gallardo L.
PMID: 30449947
Biol Sport. 2018 Sep;35(3):291-299. doi: 10.5114/biolsport.2018.77829. Epub 2018 Aug 27.

The aim of this research was to evaluate the influence of game surface and pitch size on the physiological responses, jump performance and perceptions of sub-elite female soccer players playing four-a-side games. Sixteen sub-elite female soccer players were divided...

Cite
López-Fernández J, Sánchez-Sánchez J, Rodríguez-Cañamero S, et al. Physiological responses, fatigue and perception of female soccer players in small-sided games with different pitch size and sport surfaces. Biol Sport. 2018;35(3):291-299doi: 10.5114/biolsport.2018.77829.
López-Fernández, J., Sánchez-Sánchez, J., Rodríguez-Cañamero, S., Ubago-Guisado, E., Colino, E., & Gallardo, L. (2018). Physiological responses, fatigue and perception of female soccer players in small-sided games with different pitch size and sport surfaces. Biology of sport, 35(3), 291-299. https://doi.org/10.5114/biolsport.2018.77829
López-Fernández, Jorge, et al. "Physiological responses, fatigue and perception of female soccer players in small-sided games with different pitch size and sport surfaces." Biology of sport vol. 35,3 (2018): 291-299. doi: https://doi.org/10.5114/biolsport.2018.77829
López-Fernández J, Sánchez-Sánchez J, Rodríguez-Cañamero S, Ubago-Guisado E, Colino E, Gallardo L. Physiological responses, fatigue and perception of female soccer players in small-sided games with different pitch size and sport surfaces. Biol Sport. 2018 Sep;35(3):291-299. doi: 10.5114/biolsport.2018.77829. Epub 2018 Aug 27. PMID: 30449947; PMCID: PMC6224843.
Copy Download .nbib Format: NLM
Two-Stage Surgical Treatment of Complex Femoral Deformities with Severe Coxa Vara in Polyostotic Fibrous Dysplasia.

JBJS essential surgical techniques

Ippolito E, Farsetti P, Benedetti Valentini M, Fichera A.
PMID: 30237924
JBJS Essent Surg Tech. 2016 Apr 13;6(2):e14. doi: 10.2106/JBJS.ST.15.00050. eCollection 2016 Jun 22.

No abstract available.

Cite
Ippolito E, Farsetti P, Benedetti Valentini M, et al. Two-Stage Surgical Treatment of Complex Femoral Deformities with Severe Coxa Vara in Polyostotic Fibrous Dysplasia. JBJS Essent Surg Tech. 2016;6(2):e14doi: 10.2106/JBJS.ST.15.00050.
Ippolito, E., Farsetti, P., Benedetti Valentini, M., & Fichera, A. (2016). Two-Stage Surgical Treatment of Complex Femoral Deformities with Severe Coxa Vara in Polyostotic Fibrous Dysplasia. JBJS essential surgical techniques, 6(2), e14. https://doi.org/10.2106/JBJS.ST.15.00050
Ippolito, Ernesto, et al. "Two-Stage Surgical Treatment of Complex Femoral Deformities with Severe Coxa Vara in Polyostotic Fibrous Dysplasia." JBJS essential surgical techniques vol. 6,2 (2016): e14. doi: https://doi.org/10.2106/JBJS.ST.15.00050
Ippolito E, Farsetti P, Benedetti Valentini M, Fichera A. Two-Stage Surgical Treatment of Complex Femoral Deformities with Severe Coxa Vara in Polyostotic Fibrous Dysplasia. JBJS Essent Surg Tech. 2016 Apr 13;6(2):e14. doi: 10.2106/JBJS.ST.15.00050. eCollection 2016 Jun 22. PMID: 30237924; PMCID: PMC6145627.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 307 entries